Growth Hormone-Releaser Diet Attenuates Cognitive Dysfunction in Klotho Mutant Mice via Insulin-Like Growth Factor-1 Receptor Activation in a Genetic Aging Model

다국어 초록 (Multilingual Abstract)

Background: It has been recognized that a defect in klotho gene expression accelerates the degeneration of multiple age-sensitive traits. Accumulating evidence indicates that aging is associated with declines in cognitive function and the activity of growth hormone (GH)/insulin-like growth factor-1 (IGF-1).
Methods: In this study, we examined whether a GH-releaser diet could be effective in protecting against cognitive impairment in klotho mutant mice.
Results: The GH-releaser diet significantly induced the expression of IGF-1 and IGF-1 receptors in the hippocampus of klotho mutant mice. Klotho mutant mice showed significant memory impairments as compared with wild-type mice. In addition, the klotho mutation significantly decreased the expression of cell survival/antiapoptotic factors, including phospho-Akt (p-Akt)/phospho-glycogen synthase kinase3β (p-GSK3β), phospho-extracellular signal-related kinase (p-ERK), and Bcl-2, but significantly increased those of cell death/proapoptotic factors, such as phospho-c-jun N-terminal kinase (p-JNK), Bax, and cleaved caspase-3 in the hippocampus. Treatment with GH-releaser diet significantly attenuated both decreases in the expression of cell survival/antiapoptotic factors and increases in the expression of cell death/proapoptotic factors in the hippocampus of klotho mutant mice. In addition, klotho mutation-induced oxidative stress was significantly attenuated by the GH-releaser diet. Consequently, a GH-releaser diet significantly improved memory function in the klotho mutant mice. GH-releaser diet-mediated actions were significantly reversed by JB-1, an IGF-1 receptor antagonist.
Conclusion: The results suggest that a GH-releaser diet attenuates oxidative stress, proapoptotic changes and consequent dysfunction in klotho mutant mice by promoting IGF-1 expression and IGF-1 receptor activation.

참고문헌 (Reference)

1 Khorram O, "Use of growth hormone and growth hormone secretagogues in aging: help or harm" 44 : 893-901, 2001

2 Chromiak JA, "Use of amino acids as growth hormone-releasing agents by athletes" 18 : 657-661, 2002

3 Tivesten A, "The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction" 141 : 60-66, 2000

4 Lamberts SW, "The endocrinology of aging" 278 : 419-424, 1997

5 Atkins CM, "The MAPK cascade is required for mammalian associative learning" 1 : 602-609, 1998

6 Kurosu H, "Suppression of aging in mice by the hormone Klotho" 309 : 1829-1833, 2005

7 Shiraki-Iida T, "Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein" 424 : 6-10, 1998

8 Pap M, "Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway" 273 : 19929-19932, 1998

9 Yamamoto M, "Regulation of oxidative stress by the anti-aging hormone klotho" 280 : 38029-38034, 2005

10 Tran HY, "Protective potential of IL-6 against trimethyltin-induced neurotoxicity in vivo" 52 : 1159-1174, 2012

11 Kuro-o M, "Mutation of the mouse klotho gene leads to a syndrome resembling ageing" 390 : 45-51, 1997

12 Wolf I, "Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer" 27 : 7094-7105, 2008

13 Anamizu Y, "Klotho insufficiency causes decrease of ribosomal RNA gene transcription activity, cytoplasmic RNA and rough ER in the spinal anterior horn cells" 109 : 457-466, 2005

14 Kuro-o M, "Klotho as a regulator of oxidative stress and senescence" 389 : 233-241, 2008

15 Kuro-o M, "Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism" 15 : 437-441, 2006

16 Kuro-o M, "Klotho and aging" 1790 : 1049-1058, 2009

17 Kuro-o M, "Klotho" 459 : 333-343, 2010

18 Chen CD, "Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17" 104 : 19796-19801, 2007

19 Cross DA, "Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B" 378 : 785-789, 1995

20 Park SJ, "Inactivation of JAK2/STAT3 signaling axis and downregulation of M1 mAChR cause cognitive impairment in klotho mutant mice, a genetic model of aging" 38 : 1426-1437, 2013

21 Li SA, "Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice" 29 : 91-99, 2004

22 Matsumura Y, "Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein" 242 : 626-630, 1998

23 Pang JJ, "Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro" 286 : H1063-H1069, 2004

24 Shin EJ, "Growth hormone-releaser diet attenuates beta-amyloid(1-42)-induced cognitive impairment via stimulation of the insulin-like growth factor (IGF)-1 receptor in mice" 109 : 139-143, 2009

25 Locatelli V, "Growth hormone-independent cardioprotective effects of hexarelin in the rat" 140 : 4024-4031, 1999

26 van Dam PS, "Growth hormone, insulin-like growth factor I and cognitive function in adults" 10 (10): S69-S73, 2000

27 Shin EJ, "Growth hormone releaser attenuates beta-amyloid (1 - 42)-induced memory impairment in mice" 99 : 117-120, 2005

28 Frago LM, "Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection" 143 : 4113-4122, 2002

29 Baldanzi G, "Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT" 159 : 1029-1037, 2002

30 Trifilieff P, "Foreground contextual fear memory consolidation requires two independent phases of hippocampal ERK/CREB activation" 13 : 349-358, 2006

31 Lorenzi O, "Evidence against a direct role of klotho in insulin resistance" 459 : 465-473, 2010

32 Nagai T, "Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex" 14 : 117-125, 2007

33 Watcharasit P, "Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage" 99 : 7951-7955, 2002

34 Kashimada K, "Defects in growth and bone metabolism in klotho mutant mice are resistant to GH treatment" 174 : 403-410, 2002

35 Utsugi T, "Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging" 49 : 1118-1123, 2000

36 Nagai T, "Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress" 17 : 50-52, 2003

37 Tong L, "Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons" 24 : 6799-6809, 2004

38 Kulik G, "Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt" 17 : 1595-1606, 1997

39 Oliver CN, "Age-related changes in oxidized proteins" 262 : 5488-5491, 1987

40 English JD, "Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation" 271 : 24329-24332, 1996